ArticleBMC microbiology2026
Lactobacillus protects against lead-induced hepatotoxicity by preserving the gut barrier and microbiota remodeling.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lead (Pb) toxicity is a global health concern that primarily affects the liver. This study explored the protective effects of lactobacilli against Pb(II)-induced hepatotoxicity in mice. Three strains of lactobacilli—Lacticaseibacillus paracasei GMNL-32, Limosilactobacillus fermentum GMNL-93, and Lacticaseibacillus casei GMNL-277—were evaluated for Pb adsorption and antioxidant activity. In a chronic Pb(II) exposure mouse model, GMNL-93 and GMNL-277 more effectively mitigated Pb(II)-associated liver damage, and upregulated RNA expression of gut function-associated proteins (e.g., Cldn3, Cldn5, and Muc5). Microbiome and functional pathway analyses suggested strain-specific modes of action: GMNL-93 was associated with shifts in microbial composition and enrichment of pathways linked to redox balance and bile acid metabolism, whereas GMNL-277 was linked to enhanced thiamine-related metabolism; GMNL-32 showed comparatively limited protective. Overall, lactobacilli are promising candidates for reducing lead toxicity through directly interaction and microbiome-dependent host protection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.